Pure Global

"100 first" angioconstrictin I radioimmunoassay reagent - Taiwan Registration 20a5599c0bbac4394483f6d14ba4c543

Access comprehensive regulatory information for "100 first" angioconstrictin I radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 20a5599c0bbac4394483f6d14ba4c543 and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
20a5599c0bbac4394483f6d14ba4c543
Registration Details
Taiwan FDA Registration: 20a5599c0bbac4394483f6d14ba4c543
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"100 first" angioconstrictin I radioimmunoassay reagent
TW: โ€œ็™พ้ฆ–โ€ ่ก€็ฎกๆ”ถ็ธฎ็ด Iๆ”พๅฐ„ๅ…็–ซๅˆ†ๆž่ฉฆๅŠ‘
Risk Class 2

Registration Details

20a5599c0bbac4394483f6d14ba4c543

DHA05603352802

Company Information

Belgium

Product Details

This product uses radioimmunoassay to quantitatively detect the content of angioconin I and plasma renin activity in human EDTA plasma in vitro.

A Clinical chemistry and clinical toxicology

A.1085 Angioconstrictin I and renin test system

Input;; QMS/QSD

Dates and Status

Aug 17, 2020

Aug 17, 2025